William MD - RAPT Therapeutics Chief Officer
| RAPT Stock | USD 8.33 0.20 2.46% |
Executive
William MD is Chief Officer of RAPT Therapeutics
| Age | 58 |
| Address | 561 Eccles Avenue, South San Francisco, CA, United States, 94080 |
| Phone | 650 489 9000 |
| Web | https://www.rapt.com |
RAPT Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.3613) % which means that it has lost $0.3613 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5956) %, meaning that it created substantial loss on money invested by shareholders. RAPT Therapeutics' management efficiency ratios could be used to measure how well RAPT Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.71 in 2024. Return On Capital Employed is likely to drop to -0.88 in 2024. Total Current Liabilities is likely to drop to about 11.7 M in 2024. Liabilities And Stockholders Equity is likely to drop to about 151.1 M in 2024Management Performance
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.36 |
RAPT Therapeutics Leadership Team
Elected by the shareholders, the RAPT Therapeutics' board of directors comprises two types of representatives: RAPT Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RAPT. The board's role is to monitor RAPT Therapeutics' management team and ensure that shareholders' interests are well served. RAPT Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RAPT Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gwen Carscadden, Chief Officer | ||
| Rodney Young, Principal CFO | ||
| David Wustrow, Senior Development | ||
| William Ho, Chief Officer | ||
| Jennifer Nicholson, Senior Assurance | ||
| Michael Listgarten, General Counsel | ||
| William MD, Chief Officer | ||
| Steve Young, Vice Technology | ||
| Paul Kassner, Senior Biology | ||
| Brian MD, President CEO | ||
| Dirk Brockstedt, Chief Officer |
RAPT Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is RAPT Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.36 | ||||
| Current Valuation | 137.91 M | ||||
| Shares Outstanding | 34.8 M | ||||
| Shares Owned By Insiders | 1.84 % | ||||
| Shares Owned By Institutions | 98.16 % | ||||
| Number Of Shares Shorted | 3.18 M | ||||
| Price To Book | 2.18 X | ||||
| Price To Sales | 411.22 X | ||||
| Gross Profit | 1.53 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards RAPT Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, RAPT Therapeutics' short interest history, or implied volatility extrapolated from RAPT Therapeutics options trading.
Currently Active Assets on Macroaxis
When determining whether RAPT Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if RAPT Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Rapt Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Rapt Therapeutics Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RAPT Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy RAPT Stock please use our How to Invest in RAPT Therapeutics guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for RAPT Stock analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stocks Directory Find actively traded stocks across global markets |
Is RAPT Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RAPT Therapeutics. If investors know RAPT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RAPT Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.05) | Quarterly Revenue Growth (1.00) | Return On Assets (0.36) | Return On Equity (0.60) |
The market value of RAPT Therapeutics is measured differently than its book value, which is the value of RAPT that is recorded on the company's balance sheet. Investors also form their own opinion of RAPT Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is RAPT Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RAPT Therapeutics' market value can be influenced by many factors that don't directly affect RAPT Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RAPT Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if RAPT Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RAPT Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.